Symptom Severity of Obsessive-Compulsive Disorder Post COVID-19 Pandemic in Psychiatry Department of Tertiary Care Hospital
DOI:
https://doi.org/10.37018/QDTS8938Keywords:
Coronavirus disease, Obsessive Compulsive Disorder, YBOCSAbstract
Background: There has been considerable speculation regarding the detrimental effects of the COVID-19 pandemic on mental health. The prevalence of mental disorders is thought to increase during pandemics, and the unique circumstances of the COVID-19 pandemic may have a direct impact on obsessive-compulsive disorder (OCD) manifestation clinically. The objective of the study was to find a mean change in symptom severity of obsessive-compulsive disorder post-COVID-19 pandemic.
Patients and methods: A Qausi-experimental study was conducted at the Department of Psychiatry, Jinnah Hospital, Lahore from 05-01-2022 to 05- 07-2022. After approval of the Ethical Review Board and obtaining informed consent, data was obtained from patients focused on available Yale-Brown Obsessive-Compulsive Scale (YBOCS) scores at the start of the COVID-19 pandemic in Pakistan. These patients were re-evaluated using the YBOCS scale to determine any changes in OCD severity, defined as a 50% increase from the baseline (YBOCS) score. All data were recorded on a proforma. All data were recorded on a proforma. Data analysis was performed using IBM SPSS 21. Before and mean change in (YBOCS) was determined by paired sample t-test with a significance level of p≤0.05. Results: The mean age was 36.65±3.892 years. There were 56.7% (n=34) males whereas 43.3% (n=26) were females. Distribution of duration of disease, pre-COVID YBOC score, Post- COVID (YBOCS), and change in (YBOCS) was calculated as 3.52+1.0 years, 18.07+1.9, 28.30+2.149 and 10.33+3.001, respectively. Conclusion: In the current study we found the mean change in symptom severity of obsessive-compulsive disorder post-COVID-19 pandemic using (YBOCS) score. The rise in symptoms and overall severity observed in individuals with OCD may largely stem from the stress induced by the ongoing pandemic.Downloads
Published
How to Cite
Issue
Section
License
The Journal of Fatima Jinnah Medical University follows the Attribution Creative Commons-Non commercial (CC BY-NC) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC By-NC license restricts the use of material for commercial purposes. For further details about the license please check the Creative Commons website. The editorial board of JFJMU strives hard for the authenticity and accuracy of the material published in the journal. However, findings and statements are views of the authors and do not necessarily represent views of the Editorial Board.